CROSS VETPHARM GROUP LIMITED – Trademark Portfolio
Entity Type: 11
CROSS VETPHARM GROUP LIMITED holds 127 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 123 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 15 trademarks are registered. Notable registered marks include V, A-CYST, BIMEDA, OVAMED, and BILOVET. The owner is based in DUBLIN.
BROOMHILL ROAD, TALLAGHT,
DUBLIN 24 , IE
Showing of trademarks Trademarks
Trademark Classifications
CROSS VETPHARM GROUP LIMITED's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does CROSS VETPHARM GROUP LIMITED have?
CROSS VETPHARM GROUP LIMITED has 127 U.S. trademarks filed with the USPTO. Of these, 15 registered, 98 abandoned, 14 cancelled.
What trademark classes does CROSS VETPHARM GROUP LIMITED file in?
CROSS VETPHARM GROUP LIMITED files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are CROSS VETPHARM GROUP LIMITED's most well-known trademarks?
CROSS VETPHARM GROUP LIMITED's registered trademark portfolio includes well-known marks such as V, A-CYST, BIMEDA, OVAMED, and BILOVET. These are among 15 currently registered trademarks in the portfolio.
What is CROSS VETPHARM GROUP LIMITED's trademark registration success rate?
CROSS VETPHARM GROUP LIMITED has a 12% trademark registration rate, with 15 out of 127 resolved applications resulting in successful registration. Currently, 0 applications are pending review.